Masimo (NASDAQ:MASI) Cut to “Market Perform” at Raymond James Financial

Raymond James Financial downgraded shares of Masimo (NASDAQ:MASI) from an outperform rating to a market perform rating in a research note issued to investors on Friday, MarketBeat reports.

A number of other equities analysts have also commented on the company. Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a research note on Monday, December 1st. Wells Fargo & Company upgraded Masimo to a “hold” rating in a research note on Wednesday, March 18th. Piper Sandler lowered Masimo from an “overweight” rating to a “hold” rating and set a $180.00 target price on the stock. in a report on Tuesday, February 17th. BTIG Research downgraded Masimo from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 18th. Finally, Wolfe Research lowered Masimo from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 19th. Eight equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus target price of $181.17.

Masimo Stock Performance

Shares of MASI opened at $177.11 on Friday. The company has a market capitalization of $9.51 billion, a PE ratio of -16.80, a price-to-earnings-growth ratio of 1.79 and a beta of 1.21. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.49 and a quick ratio of 1.47. Masimo has a one year low of $125.94 and a one year high of $179.00. The company’s fifty day moving average price is $159.93 and its 200 day moving average price is $148.34.

Institutional Investors Weigh In On Masimo

Institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in Masimo by 3.7% in the 3rd quarter. Vanguard Group Inc. now owns 4,810,011 shares of the medical equipment provider’s stock valued at $709,717,000 after acquiring an additional 171,876 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its position in shares of Masimo by 1.7% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 2,663,875 shares of the medical equipment provider’s stock worth $346,464,000 after acquiring an additional 43,915 shares during the period. T. Rowe Price Investment Management Inc. grew its holdings in shares of Masimo by 9.6% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 2,330,158 shares of the medical equipment provider’s stock worth $303,061,000 after purchasing an additional 203,395 shares in the last quarter. Naya Capital Management UK Ltd. acquired a new stake in shares of Masimo during the 4th quarter worth approximately $202,984,000. Finally, Westfield Capital Management Co. LP increased its position in shares of Masimo by 7.2% during the fourth quarter. Westfield Capital Management Co. LP now owns 1,522,049 shares of the medical equipment provider’s stock valued at $197,958,000 after purchasing an additional 102,799 shares during the period. 85.96% of the stock is owned by institutional investors and hedge funds.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.